EP Patent

EP2519230B1 — Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

Assigned to Marius Pharmaceuticals LLC · Expires 2018-10-10 · 8y expired

What this patent protects

Patent listed against Aveed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2519230B1
Jurisdiction
EP
Classification
—
Expires
2018-10-10
Drug substance claim
No
Drug product claim
No
Assignee
Marius Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.